Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2017 Mar 21;12(1):58.
doi: 10.1186/s13023-017-0610-8.

Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients

Affiliations
Case Reports

Combined methylmalonic acidemia and homocysteinemia presenting predominantly with late-onset diffuse lung disease: a case series of four patients

Jinrong Liu et al. Orphanet J Rare Dis. .

Abstract

Combined methylmalonic acidemia (MMA) and homocysteinemia are a group of autosomal recessive disorders caused by inborn errors of cobalamin metabolism, including CblC, D, F, and J, with cblC being the most common subtype. The clinical manifestations of combined MMA and homocysteinemia vary, but typically include neurologic, developmental and hematologic abnormalities.We report 4 children with combined MMA and homocysteinemia who presented predominantly with late-onset diffuse lung diseases (DLD). Of these, 3 accompanied by pulmonary arterial hypertension (PAH), 1 accompanied by hypertension, and 2 accompanied by renal thrombotic microangiopathy (TMA), which was confirmed by renal biopsy. This confirms combined MMA and homocysteinemia should be considered in the differential diagnosis of DLD with or without PAH or renal TMA.

Keywords: Children; Diffuse Lung disease; Homocysteinemia; Homocystinuria; Hypertension arterial pulmonary; Methylmalonic acidemia.

PubMed Disclaimer

Figures

Fig. 1
Fig. 1
Lung CT showing the presence in both lungs of 1a diffuse ground-glass opacification predominant in lower region of lung and areas with smooth thickening of interlobular septum (on admission; Patient 1), 1b absence of abnormal pulmonary feature(after 1 month of treatment; Patient 1), 2a interlobular septal thickening and bilateral pleural effusion (1 year before admission; Patient 2), 2b diffuse poorly defined centrilobular nodules(5 days after treatment; Patient 2), 2c pulmonary artery (PA) with an enlarged diameter exceeding the aorta(5 days after treatment; Patient 2), and 3 diffuse poorly defined ground-glass centrilobular nodules(on admission; Patient 3)

References

    1. Arroliga AC, Sandur S, Jacobsen DW, Tewari S, Mustafa M, Mascha EJ, et al. Association between hyperhomocysteinemia and primary pulmonary hypertension. Respir Med. 2003;97(7):825–9. doi: 10.1016/S0954-6111(03)00038-6. - DOI - PubMed
    1. Wuillemin WA, Solenthaler M. Hyperhomocysteinemia: a risk factor for arterial and venous thrombosis. Vasa. 1999;28(3):151–5. doi: 10.1024/0301-1526.28.3.151. - DOI - PubMed
    1. Profitlich L, Kirmse B, Wasserstein MP, Diaz G, Srivastava S. Resolution of cor pulmonale after medical management in a patient with cblC-type methylmalonic aciduria and homocystinuria: a case report. Cases J. 2009;2:8603. doi: 10.4076/1757-1626-2-8603. - DOI - PMC - PubMed
    1. Gunduz M, Ekici F, Ozaydin E, Ceylaner S, Perez B. Reversible pulmonary arterial hypertension in cobalamin-dependent cobalamin C disease due to a novel mutation in the MMACHC gene. Eur J Pediatr. 2014;173(12):1707–10. doi: 10.1007/s00431-014-2330-6. - DOI - PubMed
    1. Iodice FG, Di Chiara L, Boenzi S, Aiello C, Monti L, Cogo P, et al. Cobalamin C defect presenting with isolated pulmonary hypertension. Pediatrics. 2013;132(1):e248–51. doi: 10.1542/peds.2012-1945. - DOI - PubMed

MeSH terms

Supplementary concepts